DLA Piper, Sidley Guide $1.8B Deal For Disease Testing Biz
Biotechnology giant Roche said Monday it is buying diagnostics business GenMark and its technology to test for a range of diseases at once, including COVID-19, in a $1.8 billion deal guided...To view the full article, register now.
Already a subscriber? Click here to view full article